Wall Street analysts will be watching closely when Bristol-Myers Squibb Company (NYSE:BMY) reports its quarterly earnings next, which is scheduled for Thu 25 Apr (In 74 Days). Looking at the latest analyst forecasts, the current earnings-per-share (EPS) consensus estimate is sitting at $1.08 per share. In the preceding quarter, the company reportedly generated EPS of $0.94 per share of its common stock. Looking at profitability indicators, this organization has an operating margin of 20.00%, a profit margin of 1.70% and a gross margin of 71.40%.
Speaking of Wall Street analysts, a number of market experts at top investment banks have recently posted their updated ratings on shares of Bristol-Myers Squibb Company (NYSE:BMY). Most recently, on January 15th, 2019, Societe Generale Upgrade a Buy rating. Before that, on October 22nd, 2018, Citigroup Downgrade to Neutral. Guggenheim Resumed a Neutral rating on October 9th, 2018, Atlantic Equities Upgrade an Neutral rating on August 8th, 2018, and Morgan Stanley Downgrade a Equal-Weight rating on April 17th, 2018.
At its current price point, combined with the fact that this company has 1.64B shares outstanding, the current market capitalization sits at 82.12B. In the last trading day, 9,717,250 shares of Bristol-Myers Squibb Company were traded, which compares to its usual volume of about 13.86M shares per day of trading.
If we compare this company’s current price to its recent pricing activity, we can see that the price has changed by $0.33 in the past five trading days, resulting in a percentage change of +0.66% and a moving average of 50.48. In the past 20 days, its price changed by $2.50 (which is +5.24%) and the stock’s moving average was 49.47. Looking back a full 50 days, shares of BMY changed by -$2.51 (which is -4.76%) and demonstrated a moving average of 50.28.
Staying in the same analytical area, this company’s stock has demonstrated a 9-day Stochastic %K score of 77.54%, a 14-day Stochastic %K score of 77.54% and a 20-day Stochastic %K score of 83.23%. Using a similar metric, Bristol-Myers Squibb Company (BMY) shares showed a Stochastic %D of 81.50% over the past 9 days, a Stochastic %D score of 81.50% over the last 14 days, and a 20-day Stochastic %D of 86.81%. Meanwhile, this stock’s MACD Oscillator was 0.60 over the past 9 days, 0.84 over the past two weeks, and 1.00 in the last 20 days.
As recent trading data suggests, this company’s shares have been hovering close to the $50.22 level. Over the past 12 months, this stock has experienced a high price of $70.05 and a low of $44.30. Top market experts pay heightened attention to a stock as it is getting closer to a notable historic high price or low price.
Wellington Management Co LLP purchased more shares of this company during the last fiscal quarter, as we can observe in the latest corresponding filing from Bristol-Myers Squibb Company (NYSE:BMY) with the Securities and Exchange Commission (SEC). This specific major shareholder, at the end of the quarter, held 141,668,267 shares of the company’s stock following the addition of 45,074 to this investor’s holdings during the three-month period. This share count represents that Wellington Management Co LLP now held 8.68% stake in Bristol-Myers Squibb Company (BMY)’s shares.
Just in the most recent trading day, Bristol-Myers Squibb Company (NYSE:BMY) experienced a high price of $50.25 and low point of $49.58. At the end of the last trading session, this stock was at 50.22 per share, following a loss of -$0.34, or 0.34% during the full day.